Epsilon M&A Deal Report - Omega Pharma
Transaction Multiples for the Valuation of Private Companies
Perrigo Co / Omega Pharma
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Personal Products
EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
---|---|---|---|---|---|---|---|---|
Historic | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|
Current | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Multiple available |
n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Pharmaceuticals » = 129
- Number of EMAT Reports / sub-sector « Personal Products » = 133
Date | Acquirer | Target | Country | Multiples | See details |
28/10/2015 | Karo Bio | MedCore | Sweden | ** | 75827 |
28/02/2013 | Omega Pharma | Arterin | Belgium | ** | 75812 |
Source: Epsilon Research / EMAT